Author: healthadmin
Scientists have developed an AI-powered MRI body composition calculator using data from more than 66,000 adults to uncover how hidden age-related changes in fat and muscle can indicate future risk of diabetes, heart disease, and premature death. Research: Body Composition in the General Population: A Reference Curve from Whole-body MRI of More than 66,000 People. Image credit: Radiology Imaging/Shutterstock.com In a recent study published in RadiologyResearchers estimated body composition (BC) indicators from magnetic resonance imaging (MRI) scans of the general population. MRI body composition reveals hidden risk of cardiometabolic diseases Computed tomography (CT) and MRI are critical in supporting diagnosis,…
Chronic kidney disease (CKD) affects hundreds of millions of people worldwide and is one of the leading causes of kidney failure. As the disease progresses, many patients eventually require dialysis to survive. Although current treatments can slow the damage, there are still no approved drugs that directly restore kidney function. Researchers at Tohoku University Graduate School of Medicine have discovered an unexpected possibility related to a drug long used to treat constipation. A clinical trial found that the drug lubiprostone slows the decline in kidney function in patients with moderate CKD, raising hopes for an entirely new approach to treating…
Analyzing around 10,000 UK news articles, researchers found that while type 1 diabetes is often depicted through medical and biological narratives, coverage of type 2 diabetes often emphasizes lifestyle and personal responsibility, ignoring the broader social and economic factors that shape disease risk and management. Research: Type 1 and type 2 diabetes in the UK press: A diachronic corpus-based analysis. Image credit: Maya Kruchankova / Shutterstock.com In a recent study published in pro swanresearchers investigated how diabetes is represented in the UK news media and whether this representation leads to misconceptions and stigma. How the media affects diabetes awareness Current…
A Hiroshima University study of more than 31,000 patients found that pneumonia occurred more frequently after breathing tubes were removed than during mechanical ventilation, with most cases occurring within one to two weeks after surgery. This finding suggests that this underrecognized condition may be a distinct clinical entity associated with swallowing dysfunction and that early assessment and intervention, including identification of high-risk patients, may be key to prevention and improved outcomes. Pneumonia that develops after endotracheal tube removal can have a significant impact on recovery and quality of life. Ventilators to assist with breathing are a common life-saving procedure during…
Advanced inference-based AI systems have shown physician-level performance in selected diagnostic tasks, but researchers warn that real-world safety, bias, and clinical liability remain major barriers to medical deployment. Study: AI can reason like a doctor – what happens next? Image credit: Thandon88 / Shutterstock.com Recently published Perspective articles science We investigate whether advanced artificial intelligence (AI) systems are approaching physician-level reasoning and consider the implications and safety of their integration into clinical practice. Advances in AI and diagnostic reasoning Large-scale language models (LLMs) are AI algorithms trained on large amounts of data to learn patterns used to generate human-like responses.…
In 2026, the United States finds itself in a strange situation. Despite facing an impending energy shortage, the Trump administration has struck a deal to pay offshore wind developers about $2 billion in taxes to exit energy projects. These politically motivated moves are harming the American people far more than mere acquisitions. The community has been laying the groundwork for ocean energy projects for many years. Offshore wind energy development brings jobs and economic development that will reshape local economies, with public and private investments reaching hundreds of billions of dollars over the years. East Coast communities built ports to…
A very promising vaccine against hantavirus is being developed by researchers at the University of Bath. The team is led by Professor Asel Saltbaeva, a chemistry researcher at the university and co-founder of the university spin-out company Encilitec. This will be a completely new vaccine. To date, it has been tested in both laboratory and animal models with excellent immune responses. The research team expects to advance to Phase 1 human clinical trials in the near future. There is currently no effective vaccine against hantaviruses, leaving large populations in Southeast Asia, Africa, and South America vulnerable to the disease, which…
GSK has teamed up with Modern Family stars Julie Bowen and Ty Burrell to drive the ‘do-your-know’ message about the risk of meningococcal disease. The disease is most prevalent among teenagers and young adults, ages 16 to 23, who have the highest incidence of meningitis. Small-scale epidemics may also occur in universities and schools due to the close quarters. The disease is deadly and can lead to death within just 24 hours of the onset of symptoms. Even if they survive, if the infection is not caught in time, they can remain in critical condition for several weeks and face…
Climate change health impacts are accelerating, merging with pollution to pose profound threats. Discover data-driven insights on heatwaves, air pollution, wildfires, vector-borne diseases, and strategies for urban resilience and sustainability.
The PD-1xVEGF research that Summit Therapeutics had been focusing on surprisingly missed the mark in the interim analysis. UCB will pay $2 billion upfront to acquire Candid Therapeutics, a group of Chinese assets. Johnson & Johnson has discontinued two CD20 CAR-T programs it had licensed from Chinese biotech company Avelzeta Pharma. moreover. 1. Summit’s PD-1xVEGF midterm exam failure surprises analysts and sends stock price down To the dismay of investors, an interim analysis of the squamous epithelial cohort in Summit Therapeutics’ global Harmoni-3 trial of ivonocisimab in first-line non-small cell lung cancer clearly did not meet statistical significance for progression-free…